Skip to main content
. 2021 Mar 5;13(5):1123. doi: 10.3390/cancers13051123
ACT Adoptive cell transfer
AKT protein kinase B
APCs Antigen presenting cells
ATP Adenosine triphosphate
B-ALL B cell acute lymphoblastic leukemia
Bcl-X(L) B-cell lymphoma-extra large
CAFs Cancer-associated fibroblasts
CAR Chimeric antigen receptor
CAR-M Chimeric antigen receptor macrophage
CAR-Ps Chimeric antigen receptors for phagocytosis
CAT Catalase
CCR Chimeric costimulatory receptor
CLL Chronic lymphocytic leukemia
CRISPR Clustered Regularly Interspaced Short Palindromic Repeats
CRS Cytokine release syndrome
ECM Extracellular matrix
ETBR Endothelin B receptor
FAO Fatty acid oxidation
GLUT1 Glucose transporter 1
HER2 Human epidermal growth factor receptor 2
HK Hexokinase 2
HPSE Heparinase
HSPG Heparan sulphate proteoglycans
ICOS Inducible T cell co-stimulator
IDO Indoleamine-2,3-dioxygenase
IL-10 Interleukin 10
LBCL Large B cell lymphoma
MDSC Myeloid-derived suppressor cells
MICA Major histocompatibility complex class I polypeptide-related sequence A
NK Natural killer
OXPHOS Oxidative phosphorylation
PD-1 Programmed cell death protein 1
PD-L1 Programmed cell death ligand 1
PFK-6 phosphofructo-2-kinase
PGC1-α PPAR-gamma coactivator 1-α
PGE2 Prostaglandin E2
PI3K Phosphoinositide 3-kinase
PSMA Prostate-specific membrane
ROS Reactive oxygen species
ScFv Single chain variable fragment
TAA Tumor-associated antigens
TCR T cell receptor
TGFβ Transforming growth factor beta
TILs Tumor-infiltration lymphocytes
TME Tumor microenvironment
VEGF Vascular endothelial growth factor